Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Myeloproliferative disorder: Which Medications Are Safest? (29 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

29 medications are used for Myeloproliferative disorder, with 128 combined adverse event reports. The most reported drugs for Myeloproliferative disorder are RUXOLITINIB and JAKAFI.

128
Total Reports
29
Drugs Used

All Medications for Myeloproliferative disorder Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
RUXOLITINIB OPZELURA 41 10,908 14,461 16.0%
JAKAFI - 29 152 214 8.7%
HYDROXYUREA Hydroxyurea 8 664 2,103 11.1%
LENALIDOMIDE LENALIDOMIDE 8 35,942 86,495 10.3%
DEFERASIROX Deferasirox 6 2,661 4,008 23.5%
AZACITIDINE Azacitidine 5 6,641 9,028 34.4%

View all 29 drugs →

Most Reported Drugs for Myeloproliferative disorder

#1 most reported
#2 most reported
#3 most reported